Publikationen in Zusammenarbeit mit Forschern von Fundación Jiménez Díaz (69)

2024

  1. Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer

    Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049

2023

  1. Expresión de factor V de la coagulación en distintas etapas del desarrollo embrionario en ratón

    LXIV Congreso Nacional de la SEHH. XXXVIII Congreso Nacional SETH. 38th World Congress of the International Society of Hematology (ISTH)

  2. Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

    Cancers, Vol. 15, Núm. 4

2022

  1. CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation

    Hypertension, Vol. 79, Núm. 3, pp. E42-E55

  2. Molecular Mechanisms of Kidney Injury and Repair

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  4. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

2021

  1. Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm

    Circulation, Vol. 143, Núm. 21, pp. 2091-2109

2019

  1. Urinary excretion of parathyroid hormone-related protein correlates with renal function in control rats and rats with cisplatin nephrotoxicity

    American journal of physiology. Renal physiology, Vol. 317, Núm. 4, pp. F874-F880

2017

  1. 2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications

    Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485

  2. Oxidative stress in human atherothrombosis: Sources, markers and therapeutic targets

    International Journal of Molecular Sciences, Vol. 18, Núm. 11

2016

  1. BRCA2 gene mutations and coagulation-associated biomarkers

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 415-423

2015

  1. Biocompatibility reduces inflammation-induced apoptosis in mesothelial cells exposed to peritoneal dialysis Fluid

    Blood Purification, Vol. 39, Núm. 1-3, pp. 200-209

  2. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

    American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433

2014

  1. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 2, pp. 293-303

  2. Osteoprotegerin and kidney disease

    Journal of Nephrology, Vol. 27, Núm. 6, pp. 607-617

  3. TWEAK and the progression of renal disease: Clinical translation

    Nephrology Dialysis Transplantation, Vol. 29, Núm. SUPPL. 1

  4. Unilateral ureteral obstruction: Beyond obstruction

    International Urology and Nephrology, Vol. 46, Núm. 4, pp. 765-776

2013

  1. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells

    Nephron - Experimental Nephrology, Vol. 122, Núm. 1-2, pp. 62-74

  2. Laser therapy in metabolic syndrome-related kidney injury

    Photochemistry and Photobiology, Vol. 89, Núm. 4, pp. 953-960